Despite Bolsonaro Objection, China in Running to Provide Vaccine to Brazil
NEW DELHI Competing Brazilian politicians have ended up inviting both China’s Sinovac and India’s Serum Institute for COVID-19 vaccines amid delays in the production of Brazil’s own vaccine.
Meanwhile, the country’s private clinics have turned to another Indian vaccine producer, Bharat Biotech, for 5 million doses of its COVID-19 vaccine called Covaxin.
Brazil has the third-highest cases of CCP virus, but, despite having the capacity to produce the vaccine, the country’s administration couldn’t achieve the timely production of a home-made vaccine.
President Jair Bolsonaro’s rival and contender in the 2022 presidential race, the governor of Sao Paulo, Joao Doria, invited China’s Sinovac to supply its Coronavac vaccine for the 44 million residents of his province.
SAO PAULO (AP) A vaccine candidate made by China’s Sinovac is 78% effective in protecting against the coronavirus, according to results of a study announced Thursday by Brazilian state health.
File photo
NEW DELHI: India and China are quite unwittingly on opposing sides of a heated political debate in Brazil, a battle royal between Covishield by the Serum Institute and Coronavac by China’s Sinovac.
Brazilian president Jair Bolsonaro, who does not have a healthy fear of Covid, did not focus too much on securing vaccines for his people, even though Brazil is, like India, one of the world’s top vaccine-producing countries.
However, things became serious when the governor of Sao Paulo, Joao Doria, Bolsonaro’s political opponent and a potential contender for the presidency in 2022 declared in December 2020, that he would vaccinate 44 million residents of his province with the Coronavac, developed by China’s Sinovac.